Allan J. Pantuck

Career Trajectory

Research Cluster Map

Direct collaborators. Node size = influence, colour = community, dashed = past collaboration.

• First, Do No Harm

  Journal of the National Comprehensive Cancer Network · 2026-03-01

• RANDOMIZED, DOUBLE-BLIND, PLACEBO CONTROLLED PHASE 1 STUDY OF ATH-063: A NOVEL, ORAL, ARTIFICIAL INTELLIGENCE-GENERATED DRUG FOR INFLAMMATORY BOWEL DISEASE

  Gastroenterology · 2026-01-22

• Frontiers in Systemic Therapy for Unresectable or Metastatic Adrenocortical Carcinoma: Harnessing Novel Therapeutic Approaches

  Clinical Medicine Insights Oncology · 2025-01-01 · 1 citations

• Clinical trials: Getting started

  Elsevier eBooks · 2024-10-04

• [89Zr]Zr-girentuximab for PET–CT imaging of clear-cell renal cell carcinoma: a prospective, open-label, multicentre, phase 3 trial

  The Lancet Oncology · 2024-09-10 · 127 citations

• Gene and Protein Expression of MAGE and Associated Immune Landscape Elements in Non–Small-Cell Lung Carcinoma and Urothelial Carcinomas

  Journal of Immunotherapy · 2024-08-22 · 1 citations